Therapeutic challenges in renal cell carcinoma.

  • Penticuff J
  • Kyprianou N
  • 8


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Renal cell carcinoma (RCC) is a malignancy that in advanced disease, is highly resistant to systemic therapies. Elucidation of the angiogenesis pathways and their intrinsic signaling interactions with the genetic and metabolic disturbances within renal cell carcinoma variants has ushered in the era of "targeted therapies". Advanced surgical interventions and novel drugs targeting VEGF and mTOR, have improved patient survival and prolonged clinically stable-disease states. This review discusses the current understanding of diagnostic challenges and the mechanism-based clinical evidence on therapeutic management of advanced RCC.

Author-supplied keywords

  • Angiogenesis
  • imaging
  • renal cancer
  • survival signaling
  • targeted therapies

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Justin C Penticuff

  • Natasha Kyprianou

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free